Related Experiment Video
Updated: Aug 12, 2026
09:04
Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
Published on: September 7, 2010
Sialidases: structures, biological significance and therapeutic potential
1School of Biology and Biochemistry, University of Bath, Claverton Down, UK. g.l.taylor@bath.ac.uk
Current Opinion in Structural Biology
|December 1, 1996
Summary
Structure-based drug design yielded a potent influenza neuraminidase inhibitor. This success in treating influenza may guide the development of drugs for other sialidase-related diseases due to shared structural features.
Area of Science:
- Biochemistry
- Drug Design
- Virology
Background:
- Neuraminidase (sialidase) is a key enzyme in influenza virus replication.
- Structure-based drug design has successfully yielded potent influenza inhibitors.
- Influenza drug development is a significant pharmaceutical market.
Purpose of the Study:
- To highlight the success of rational drug design in creating influenza neuraminidase inhibitors.
- To explore the potential of applying influenza sialidase knowledge to other diseases.
- To leverage structural similarities of sialidases for broader therapeutic applications.
Main Methods:
- Review of structure-based drug design principles.
- Analysis of influenza neuraminidase inhibitor development.
- Comparative structural analysis of various sialidases.
Main Results:
- A potent inhibitor of influenza neuraminidase was successfully designed.
- Clinical trials demonstrate the drug's efficacy, attracting pharmaceutical interest.
- Sialidases are implicated in the pathogenesis of numerous diseases beyond influenza.
Conclusions:
- The success in designing influenza neuraminidase inhibitors exemplifies rational drug design.
- Knowledge gained from influenza sialidase research can inform the design of drugs for other diseases.
- Targeting conserved structural features of sialidases offers a promising avenue for new drug development.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...